Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 7:20 PM ET

Life Sciences Tools and Services

Company Overview of WuXi AppTec, Inc.

Company Overview

WuXi AppTec, Inc. provides contract research and development outsourcing services for pharmaceutical, biotechnology, and medical device industries worldwide. The company offers pharmaceutical services, including discovery services in the areas of synthetic and medicinal chemistry, analytical chemistry, discovery biology, pharmacology, safety pharmacology, drug metabolism and pharmacokinetics, and bioanalysis; and development services, such as process research and development, research and commercial manufacturing, analytical development, and pharmaceutical development. It also offers biologics development, testing, and manufacturing services for mammalian-derived protein therapeutic, microbi...

2540 Executive Drive

St. Paul, MN 55120

United States

Founded in 1982





Key Executives for WuXi AppTec, Inc.

Co-Founder, Chairman of the Board, Chief Executive Officer and Member of Strategy Committee
Age: 48
Co-Founder, Senior Vice President of Operations, Head of Domestic Marketing and Director
Age: 45
Co-Founder, Executive Vice President and Director
Age: 51
Chief Financial Officer and Chief Operating Officer
Age: 52
Senior Vice President of Operations, Head of Corporate Human Resources and Director
Age: 48
Compensation as of Fiscal Year 2015.

WuXi AppTec, Inc. Key Developments

Lion Biotechnologies, Inc. Announces Agreement with WuXi AppTec, Inc. to Increase TIL Manufacturing Capacity

Lion Biotechnologies, Inc. announced that it has entered into a two-year agreement with WuXi AppTec, Inc. to provide additional TIL manufacturing capacity. The additional manufacturing capability is expected to become available within the first six months of 2016 at WuXi AppTec's facility in Philadelphia.

WuXi AppTec, Inc. Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-07-2015 01:15 PM

WuXi AppTec, Inc. Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-07-2015 01:15 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Alan Moore, Vice President of Testing and Cell Services.

REGENXBIO Inc Enters into Strategic Manufacturing Collaboration with WuXi AppTec, Inc

REGENXBIO Inc. announced that it has entered into an exclusive strategic manufacturing collaboration with WuXi AppTec, Inc. Through this collaboration, REGENXBIO plans to establish efficient, scalable manufacturing processes within current Good Manufacturing Practice guidelines for the production of adeno-associated virus gene therapy treatments incorporating REGENXBIO's NAV Technology. Under the terms of the agreement, REGENXBIO and WuXi will establish a proprietary production process for NAV Technology treatments designed to enable the rapid advancement of REGENXBIO's and licensees' therapeutic programs from clinical trials through commercialization in WuXi's 145,000 square-foot cGMP facility currently under construction in Philadelphia. This facility is specially designed to accommodate gene therapy products that contain viral vectors such as REGENXBIO's NAV Technology platform. The partnership will combine REGENXBIO's expertise in AAV process development with WuXi's commercial manufacturing proficiency and established infrastructure. As part of the collaboration, REGENXBIO has already initiated with WuXi the production of material to be used in planned clinical trials. This unique collaboration enables WuXi to work closely with REGENXBIO to provide an integrated solution to its gene therapy needs.

Similar Private Companies By Industry

Company Name Region
Criterium, Inc. United States
Fisher Scientific International Inc. United States
Sigma-Aldrich RTC, Inc. United States
Bonna-Agela Technologies Inc. United States
Veristat, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact WuXi AppTec, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at